URO TODAY: Men with low-risk prostate cancer who are candidates for active surveillance often choose definitive therapy due to anxiety over their untreated cancer. READ MORE>
Posts Tagged ‘anxiety’
Anxiety over untreated low-risk cancer pushes men to choose active therapy
Posted in PROSTATE CANCER, PROSTATE RESEARCH, Treatment debate, Watchful waiting, tagged active surveillance, anxiety, cancer research, low-risk prostate cancer, prostablog, prostate, prostate blog, PROSTATE CANCER, prostate cancer treatments, prostate treatment, prostate treatment debate, untreated cancer, URO TODAY on September 11, 2009| Leave a Comment »
New studies will look at whether ‘watchful waiting’ is best option for most men with prostate cancer
Posted in PROSTATE CANCER, PROSTATE RESEARCH, Screening debate, Watchful waiting, tagged active surveillance, anxiety, cancer research, comparison of treatments, prostablog, prostate, prostate blog, PROSTATE CANCER, prostate treatment debate, SAN ANTONIO HEALTH, Screening debate, trade-offs, Watchful waiting on August 9, 2009| Leave a Comment »
SAN ANTONIO HEALTH: Two US national studies taking place in San Antonio are focusing on watchful waiting and aim to give men more definitive answers as they consider the trade-offs between the anxiety of living with prostate cancer and the well-known side effects of surgery and radiation. READ MORE>
Little distress suffered by men with early stage prostate cancer who delay treatment
Posted in PROSTATE CANCER, PROSTATE RESEARCH, Watchful waiting, tagged American Cancer Society, anxiety, cancer, cancer research, distress, early stage prostate cancer, EUREKALERT, expectant management, prostablog, prostate, prostate blog, PROSTATE CANCER, prostate cancer treatments, prostate treatment, prostate treatment debate, Watchful waiting on July 28, 2009| Leave a Comment »
JULY 28: EUREKALERT: Men with early stages of prostate cancer who delay radical treatment in favor of an approach of “expectant management” do not have high levels of anxiety and distress, according to a new study published in Cancer, a peer-reviewed journal of the American Cancer Society. READ MORE>